BioCentury | Sep 19, 2011
Clinical News
OvPlex update
...HealthLinx said partner CytogenDx began a Chinese trial to evaluate OvPlex in 350 patients. The partners...
...co-fund the study. OvPlex has CE Mark approval in Europe and is approved in Australia. CytogenDx Co. Ltd....
...co-fund the study. OvPlex has CE Mark approval in Europe and is approved in Australia. CytogenDx Co. Ltd....